We brought Waystone Investment Management (IE) Limited (Clone) onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk:…
When ELITETRADERSBASE crossed our desk, we ran it through the same heads-up assessment we apply to every platform. The picture that emerged is one of elevated risk: ELITETRADERSBASE has drawn cautions from regulators who have…
Our analysts put Ted Set898 on the Cryptohud control room and worked the signals in order. The picture that emerged is one of elevated risk: Ted Set898 operates without verifiable authorisation from any recognised financial…
We brought Trusttradefi (Trust Trade Fi) onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: Trusttradefi (Trust…
Our analysts put HighApexPlanning on the Cryptohud control room and worked the signals in order. The picture that emerged is one of elevated risk: HighApexPlanning operates without verifiable authorisation from any recognised financial regulator. The…
We brought Kyber Network onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: Kyber Network has drawn…
Our analysts put Econam on the Cryptohud control room and worked the signals in order. The picture that emerged is one of elevated risk: Econam operates without verifiable authorisation from any recognised financial regulator. The…
We brought RAprime onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: RAprime leans on a registration…
We brought Tyrone-Trades (Imposter) onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: Tyrone-Trades (Imposter) operates without…
We brought MAVQERIS onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: MAVQERIS has drawn cautions from…